Cardiac dysfunction and noncardiac dysfunction as precursors of heart failure with reduced and preserved ejection fraction in the community.
about
Lung function and airway obstruction: associations with circulating markers of cardiac function and incident heart failure in older men-the British Regional Heart StudyMicroRNA and Heart FailureCardiovascular comorbidity in rheumatic diseases: a focus on heart failureAdvances in the epidemiology of heart failure and left ventricular remodelingHeart Disease and Stroke Statistics-2017 Update: A Report From the American Heart AssociationCardiovascular Health Status and Incidence of Heart Failure in the Framingham Offspring StudyAssociation between cardiovascular vs. non-cardiovascular co-morbidities and outcomes in heart failure with preserved ejection fraction.Developing therapies for heart failure with preserved ejection fraction: current state and future directionsUpdate on heart failure with preserved ejection fraction.Heart failure with preserved ejection fraction: molecular pathways of the aging myocardiumUsefulness of electrocardiographic QRS/T angles with versus without bundle branch blocks to predict heart failure (from the Atherosclerosis Risk in Communities Study)The role of depression in medication adherence among heart failure patientsAge and the effectiveness of anti-hypertensive therapy on improvement in diastolic function.Noncardiac comorbidities in heart failure with reduced versus preserved ejection fractionGender differences in predictors of left ventricular myocardial relaxation in non-obese, healthy individualsAssociation of cardiorespiratory fitness with left ventricular remodeling and diastolic function: the Cooper Center Longitudinal StudyEffects of human immunodeficiency virus and metabolic complications on myocardial nutrient metabolism, blood flow, and oxygen consumption: a cross-sectional analysis.Contribution of central adiposity to left ventricular diastolic function (from the Baltimore Longitudinal Study of Aging)Extracellular Vesicle Proteins Associated with Systemic Vascular Events Correlate with Heart Failure: An Observational Study in a Dyspnoea Cohort.Prevalence of left ventricular dysfunction in a UK community sample of very old people: the Newcastle 85+ studyAirflow obstruction, lung function, and risk of incident heart failure: the Atherosclerosis Risk in Communities (ARIC) studyBrachial-ankle pulse wave velocity is the only index of arterial stiffness that correlates with a mitral valve indices of diastolic dysfunction, but no index correlates with left atrial size.Burden of Systolic and Diastolic Left Ventricular Dysfunction Among Hispanics in the United States: Insights From the Echocardiographic Study of Latinos.Asymptomatic cardiac toxicity in long-term cancer survivors: defining the population and recommendations for surveillance.Ventricular conduction defects and the risk of incident heart failure in the Atherosclerosis Risk in Communities (ARIC) Study.Phenotype-Specific Treatment of Heart Failure With Preserved Ejection Fraction: A Multiorgan Roadmap.Mast Cell Inhibition Attenuates Cardiac Remodeling and Diastolic Dysfunction in Middle-aged, Ovariectomized Fischer 344 × Brown Norway Rats.The emerging epidemic of heart failure with preserved ejection fraction.Changes in mid-life fitness predicts heart failure risk at a later age independent of interval development of cardiac and noncardiac risk factors: the Cooper Center Longitudinal Study.Pilot study of pioglitazone and exercise training effects on basal myocardial substrate metabolism and left ventricular function in HIV-positive individuals with metabolic complications.Pre-clinical diastolic dysfunctionHeart Failure in Women--Insights from the Framingham Heart Study.Different patterns of bundle-branch blocks and the risk of incident heart failure in the Women's Health Initiative (WHI) studyDevelopments in heart failure 2011.Diagnosis of heart failure with preserved ejection fraction: role of clinical Doppler echocardiography.How do patients with heart failure with preserved ejection fraction die?Ventricular remodeling in heart failure with preserved ejection fraction.Heart failure with preserved ejection fraction: a clinical dilemma.Physiological geroscience: targeting function to increase healthspan and achieve optimal longevity.The relationship between arterial stiffness and heart failure with preserved ejection fraction: a systemic meta-analysis.
P2860
Q24658577-A1632F43-3D40-459C-ABF2-CB64CA42701AQ26750638-6C05D440-8907-4DC9-80D7-64F0ECD17FE3Q26823443-2B3C4926-EBF4-4211-8CF1-CD62728833ADQ26827147-0FE7DFFE-211F-4895-A5B8-F170EE0C751AQ30238784-0C987B06-8065-415D-8718-E75E69C3DB0CQ30692600-8352FC91-DEBC-403C-84BF-225F640E2310Q33164540-5BFD682F-ED07-45B7-AF77-A8ECE2128DD9Q33639223-C3441A64-C672-42EF-B1EF-0265F31A52EDQ33640339-E403B791-CDAE-4518-9D3E-92F9085126CEQ33889242-4C1BAB93-88EC-4546-975B-139CFFD09481Q33903007-340A5AA3-99DE-4EDF-BAC6-8D44BBC9B709Q34034178-5CB91E52-F465-4805-897D-4CD618BF3AEBQ34231421-4ED09496-ECB0-4FF8-86BF-37A1B0EF56B5Q34625223-5DBC7842-D042-42C2-88F0-20C672582725Q35558556-A39E6840-8F77-43AD-98D1-0BC0022F3A70Q35634804-DAB48DBC-0779-4820-A391-01CF0B8F3BABQ35672526-2F759C47-B714-4AF3-816A-8D7FE06A4F47Q35869738-1C64C500-EDA5-4EB1-8BA2-3BD18F00887CQ35907034-0789A16C-DEFF-41C8-A41F-CDDADBFDB064Q36221525-50117F9C-8D3F-40EF-8A11-7EE6B5A23AF7Q36489181-BE2814C6-E473-4A96-8B72-55A561611E01Q36711621-601FCD97-5863-4D7D-AAC4-E9E7E6087E89Q36784206-D9F8DC44-9D11-4C72-B7A8-A527E065A492Q36939536-86546491-BA80-4CE3-87D2-C1F6006E3FC3Q36949744-C9CBC162-9C1C-4B8C-B93E-5DC37B092A8EQ37058596-27B4DDC5-DDC7-4CE0-97AD-C4D095DF02B0Q37079737-3CFA6969-4AB2-495C-AA1E-80D55D696BB1Q37407880-4961EB83-F5E7-4A4E-B07F-74792143FB5FQ37495523-F197D287-DEB7-4841-A8D1-5A5BBBCF8108Q37602891-B352C98D-36D3-4D8C-97EB-DD2A68B65C76Q37603551-A1834D9C-D552-446F-BE98-B55B0F4FC6B4Q37637447-3B19AC12-B112-4493-A9A5-FE994916DF0FQ37671427-AFC4A8A0-AF40-4008-9825-E5DCB3D7672EQ37995246-3594F1AC-FCEF-4B5D-9939-DEE7D6066380Q38094642-2B364AB8-EDC3-42ED-A98F-BB8F029AE38AQ38101027-9F17FF60-5D24-4CF4-ADF9-970C09A984A0Q38149802-E23EC57E-686D-4541-B8AB-B2BFFA9F5047Q38195149-832DBB80-0582-4DB5-BF8C-185C611ED6E2Q38339672-92B337E4-1FF9-42D7-9A1F-46794934A84FQ38365349-E726C1DB-06C7-49E9-A37D-0D5F8F6B3E0E
P2860
Cardiac dysfunction and noncardiac dysfunction as precursors of heart failure with reduced and preserved ejection fraction in the community.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Cardiac dysfunction and noncar ...... ion fraction in the community.
@ast
Cardiac dysfunction and noncar ...... ion fraction in the community.
@en
type
label
Cardiac dysfunction and noncar ...... ion fraction in the community.
@ast
Cardiac dysfunction and noncar ...... ion fraction in the community.
@en
prefLabel
Cardiac dysfunction and noncar ...... ion fraction in the community.
@ast
Cardiac dysfunction and noncar ...... ion fraction in the community.
@en
P2093
P2860
P50
P1433
P1476
Cardiac dysfunction and noncar ...... ion fraction in the community.
@en
P2093
Asya Lyass
Burkert M Pieske
Carolyn S P Lam
Daniel Levy
Douglas S Lee
Elisabeth Kraigher-Krainer
Margaret M Redfield
P2860
P356
10.1161/CIRCULATIONAHA.110.979203
P407
P577
2011-06-13T00:00:00Z